腰椎小关节置换术与融合术治疗伴狭窄的I度退行性腰椎滑脱:一项前瞻性随机对照试验
这项前瞻性随机对照试验将321例单节段腰椎管狭窄伴I度退行性腰椎滑脱患者按2:1随机分配至小关节置换组(219例)或融合组(102例)。小关节置换组达到复合临床成功的比例高于融合组(73.5% vs 25.5%,p<0.001),组间差异47.9%(95%CI 33.0%至62.8%)。术后24个月时小关节置换组在多数患者报告结局指标上优于融合组,融合组症状性邻近节段退变发生率更高。
要点
- 小关节置换组复合临床成功率为73.5%,融合组为25.5%,组间差异47.9%(95%CI 33.0%至62.8%)。
- 术后24个月时小关节置换组在ODI、VAS背痛及全部ZCQ组分评分等多数患者报告结局上优于融合组。
- 两组手术变量及并发症无显著差异,但融合组症状性邻近节段退变发生率更高。
核心结论
- 在腰椎管狭窄伴I度退行性腰椎滑脱患者中,术后24个月时腰椎小关节置换术的复合临床成功率高于融合术。
研究设计与样本
- 随机对照的美国食品药品监督管理局(FDA)研究性器械豁免试验,将单节段腰椎管狭窄伴I度退行性腰椎滑脱患者分配至减压加腰椎小关节置换组或减压加融合组。
- 共321例成人患者按2:1随机化,219例分配至小关节置换组,102例分配至融合组。
- 主要结局为预先设定的复合临床成功评分,次要结局包括ODI、VAS背痛与腿痛、ZCQ、SF-12、影像学参数、手术变量及并发症。
主要发现
- 小关节置换组113例(51.6%)、融合组47例(46.1%)达到术后24个月随访或判定为早期临床失败,纳入主要结局分析。
- 小关节置换组达到复合临床成功的比例高于融合组(73.5% vs 25.5%,p<0.001),组间差异47.9%(95%CI 33.0%至62.8%)。
- 术后24个月时小关节置换组在包括ODI、VAS背痛及全部ZCQ组分评分在内的多数患者报告结局指标上优于融合组。
- 两组手术变量及并发症无显著差异,但融合组症状性邻近节段退变发生率更高。
关键数值与推荐
- 主要结局为预先设定的复合临床成功评分。
- 复合临床成功:小关节置换组73.5% vs 融合组25.5%(p<0.001),组间差异47.9%(95%CI 33.0%至62.8%)。
- 证据等级:治疗性I级。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The comparative effectiveness of decompression plus lumbar facet arthroplasty versus decompression plus instrumented lumbar spinal fusion in patients with lumbar spinal stenosis and grade-I degenerative spondylolisthesis is unknown. METHODS: In this randomized, controlled, Food and Drug Administration Investigational Device Exemption trial, we assigned patients who had single-level lumbar spinal stenosis and grade-I degenerative spondylolisthesis to undergo decompression plus lumbar facet arthroplasty (arthroplasty group) or decompression plus fusion (fusion group). The primary outcome was a predetermined composite clinical success score. Secondary outcomes included the Oswestry Disability Index (ODI), visual analog scale (VAS) back and leg pain, Zurich Claudication Questionnaire (ZCQ), Short Form (SF)-12, radiographic parameters, surgical variables, and complications. RESULTS: A total of 321 adult patients were randomized in a 2:1 fashion, with 219 patients assigned to undergo facet arthroplasty and 102 patients assigned to undergo fusion. Of these, 113 patients (51.6%) in the arthroplasty group and 47 (46.1%) in the fusion group who had either reached 24 months of postoperative follow-up or were deemed early clinical failures were included in the primary outcome analysis. The arthroplasty group had a higher proportion of patients who achieved composite clinical success than did the fusion group (73.5% versus 25.5%; p < 0.001), equating to a between-group difference of 47.9% (95% confidence interval, 33.0% to 62.8%). The arthroplasty group outperformed the fusion group in most patient-reported outcome measures (including the ODI, VAS back pain, and all ZCQ component scores) at 24 months postoperatively. There were no significant differences between groups in surgical variables or complications, except that the fusion group had a higher rate of developing symptomatic adjacent segment degeneration. CONCLUSIONS: Among patients with lumbar spinal stenosis and grade-I degenerative spondylolisthesis, lumbar facet arthroplasty was associated with a higher rate of composite clinical success than fusion was at 24 months postoperatively. LEVEL OF EVIDENCE: Therapeutic Level I . See Instructions for Authors for a complete description of levels of evidence.
引用
- Nassr A, Coric D, Pinter ZW, et al. Lumbar Facet Arthroplasty Versus Fusion for Grade-I Degenerative Spondylolisthesis with Stenosis: A Prospective Randomized Controlled Trial. J Bone Joint Surg Am. 2024. PMID: 38713762. doi:10.2106/JBJS.23.00719
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。